
ANA5 Funnel Catheter by ANACONDA Biomed Gets CE Mark, Unlocking New Era in Stroke Thrombectomy
In a recent conversation with MedTech Spectrum, Trent Reutiman, CEO of ANACONDA Biomed, shared insights into the company’s CE Mark approval for the ANA5 Funnel Catheter—a next-generation device designed to improve clot capture and procedural outcomes in acute ischemic stroke treatment.